back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-04 21:59 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-936.00
-200 vol $4.68 each |
3,924 | |
| Filed 2024-04-04 21:57 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,398
-300 vol $4.66 each |
199,776 | |
| Filed 2024-04-04 21:55 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,910.60
-410 vol $4.66 each |
41,541 | |
| Filed 2024-04-04 21:53 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,637.29
-789 vol $4.61 each |
12,245 | |
| Filed 2024-04-04 21:51 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,185
-900 vol $4.65 each |
25,382 | |
| Filed 2024-04-04 21:50 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,398
-300 vol $4.66 each |
26,282 | |
| Filed 2024-04-04 21:48 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-11,533.33
-2,491 vol $4.63 each |
21,219 | |
| Filed 2024-03-28 20:43 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,811.50
-825 vol $4.62 each |
13,034 | |
| Filed 2024-03-28 20:42 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,811.50
-825 vol $4.62 each |
13,859 | |
| Filed 2024-03-28 20:38 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,795
-825 vol $4.60 each |
14,684 | |
| Filed 2024-03-28 20:37 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-3,951.75
-825 vol $4.79 each |
15,509 | |
| Filed 2024-03-28 20:33 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,325
-500 vol $4.65 each |
4,124 | |
| Filed 2024-03-28 20:32 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,310
-500 vol $4.62 each |
4,624 | |
| Filed 2024-03-28 20:32 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,305
-500 vol $4.61 each |
5,124 | |
| Filed 2024-03-28 20:31 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,395
-500 vol $4.79 each |
5,624 | |
| Filed 2024-03-28 20:29 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,088
-450 vol $4.64 each |
41,951 | |
| Filed 2024-03-28 20:28 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,079
-450 vol $4.62 each |
42,401 | |
| Filed 2024-03-28 20:28 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,074.50
-450 vol $4.61 each |
42,851 | |
| Filed 2024-03-28 20:28 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,151
-450 vol $4.78 each |
43,301 | |
| Filed 2024-03-28 20:26 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,320
-500 vol $4.64 each |
200,076 | |
| Filed 2024-03-28 20:25 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,310
-500 vol $4.62 each |
200,576 | |
| Filed 2024-03-28 20:24 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,300
-500 vol $4.60 each |
201,076 | |
| Filed 2024-03-28 20:24 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,390
-500 vol $4.78 each |
201,576 | |
| Filed 2024-03-28 20:22 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,243
-2,650 vol $4.62 each |
23,710 | |
| Filed 2024-03-28 20:21 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,269.50
-2,650 vol $4.63 each |
26,360 | |
| Filed 2024-03-28 20:20 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,296
-2,650 vol $4.64 each |
29,010 | |
| Filed 2024-03-28 20:19 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,693.50
-2,650 vol $4.79 each |
31,660 | |
| Filed 2024-03-28 20:17 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,415.20
-305 vol $4.64 each |
26,582 | |
| Filed 2024-03-28 20:17 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,185
-900 vol $4.65 each |
26,887 | |
| Filed 2024-03-28 20:16 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,403
-305 vol $4.60 each |
27,787 | |
| Filed 2024-03-28 20:15 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,149
-900 vol $4.61 each |
28,092 | |
| Filed 2024-03-28 20:15 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,403
-305 vol $4.60 each |
28,992 | |
| Filed 2024-03-28 20:14 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,149
-900 vol $4.61 each |
29,297 | |
| Filed 2024-03-28 20:13 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,460.95
-305 vol $4.79 each |
30,197 | |
| Filed 2024-03-28 20:13 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,302
-900 vol $4.78 each |
30,502 | |
| Filed 2024-03-28 20:09 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,134.44
-462 vol $4.62 each |
23,416 | |
| Filed 2024-03-28 20:08 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,171.40
-470 vol $4.62 each |
23,878 | |
| Filed 2024-03-28 20:07 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,171.40
-470 vol $4.62 each |
24,348 | |
| Filed 2024-03-28 20:06 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-2,251.30
-470 vol $4.79 each |
24,818 | |
| Filed 2024-03-22 18:29 Tx date 2024-03-20 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$39,962
+5,750 vol $6.95 each |
6,124 | |
| Filed 2024-03-22 18:28 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-5,750 vol |
26,500 | |
| Filed 2024-03-22 18:26 Tx date 2024-03-20 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,871
+8,183 vol $6.95 each |
43,751 | |
| Filed 2024-03-22 18:23 Tx date 2024-03-20 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,278
+8,817 vol $6.95 each |
202,076 | |
| Filed 2024-03-22 18:20 Tx date 2024-03-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$154,873
+22,284 vol $6.95 each |
31,402 | |
| Filed 2024-03-22 18:18 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-22,284 vol |
55,566 | |
| Filed 2024-03-22 18:16 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,871
+8,183 vol $6.95 each |
||
| Filed 2024-03-22 18:16 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-8,183 vol |
30,367 | |
| Filed 2024-03-22 18:08 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,278
+8,817 vol $6.95 each |
||
| Filed 2024-03-22 18:07 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-8,817 vol |
31,633 | |
| Filed 2024-03-22 18:05 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$26,013
+3,743 vol $6.95 each |
25,288 | |
| Filed 2024-03-22 18:04 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-3,743 vol |
15,487 | |
| Filed 2024-03-22 17:54 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,830
+8,177 vol $6.95 each |
16,334 | |
| Filed 2024-03-22 17:53 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-8,177 vol |
30,353 | |
| Filed 2024-03-22 17:49 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$181,971
+26,183 vol $6.95 each |
34,310 | |
| Filed 2024-03-22 17:44 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-26,183 vol |
92,367 | |
| Filed 2024-03-04 19:34 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,820
+2,000 vol $5.91 each |
8,157 | |
| Filed 2024-03-04 19:30 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,210
+374 vol $5.91 each |
374 | |
| Filed 2024-03-04 19:27 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,820
+2,000 vol $5.91 each |
8,127 | |
| Filed 2024-03-04 19:17 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,213
+1,559 vol $5.91 each |
1,559 | |
| Filed 2024-03-04 19:13 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,289
+1,741 vol $5.91 each |
21,545 | |
| Filed 2024-03-04 09:47 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$417,000
+60,000 vol $6.95 each |
300,000 | |
| Filed 2024-03-04 09:46 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2024-03-04 09:45 Tx date 2023-05-09 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-04 09:44 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$660,250
+95,000 vol $6.95 each |
420,400 | |
| Filed 2024-03-04 09:42 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+15,000 vol |
32,250 | |
| Filed 2024-03-04 09:40 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,750
+85,000 vol $6.95 each |
734,090 | |
| Filed 2024-03-04 09:39 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+14,000 vol |
38,530 | |
| Filed 2024-03-04 09:37 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,750
+85,000 vol $6.95 each |
597,410 | |
| Filed 2024-03-04 09:36 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+14,000 vol |
40,450 | |
| Filed 2024-03-04 09:32 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,750
+85,000 vol $6.95 each |
636,593 | |
| Filed 2024-03-04 09:31 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+14,000 vol |
38,550 | |
| Filed 2024-03-04 09:24 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$486,500
+70,000 vol $6.95 each |
612,139 | |
| Filed 2024-03-04 09:23 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+11,000 vol |
77,850 | |
| Filed 2024-03-04 09:19 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$312,750
+45,000 vol $6.95 each |
537,396 | |
| Filed 2024-03-04 09:17 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+8,000 vol |
19,230 | |
| Filed 2024-03-04 09:13 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,647,150
+237,000 vol $6.95 each |
2,403,376 | |
| Filed 2024-03-04 09:10 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+40,000 vol |
118,550 | |
| Filed 2023-12-27 17:57 Tx date 2023-05-09 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-27 17:51 Tx date 2022-01-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-27 17:48 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
12,312 | |
| Filed 2023-12-27 17:45 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
19,804 | |
| Filed 2023-12-27 17:42 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
46,041 | |
| Filed 2023-12-27 17:38 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
101,006 | |
| Filed 2023-12-27 17:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2023-12-27 17:31 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-12-22 17:01 Tx date 2022-01-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-21 22:09 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-12-21 17:00 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
||
| Filed 2022-12-21 16:56 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-12-21 16:53 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
||
| Filed 2022-12-21 16:49 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
||
| Filed 2022-12-21 16:39 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-03-15 18:51 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
||
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:22 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2021-12-10 17:13 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
||
| Filed 2021-12-07 09:43 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
||
| Filed 2023-12-11 20:27 Tx date 2023-12-11 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$277,787
+43,746 vol $6.35 each |
193,259 | |
| Filed 2023-12-11 20:26 Tx date 2023-12-11 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-277,787.10
-43,746 vol $6.35 each |
512,410 | |
| Filed 2023-06-12 19:23 Tx date 2023-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-41,522
-3,194 vol $13.00 each |
9,118 | |
| Filed 2023-06-12 09:43 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
168,133 | |
| Filed 2023-06-12 09:41 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
187,928 | |
| Filed 2023-06-12 09:40 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
136,107 | |
| Filed 2023-06-12 09:39 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
168,133 | |
| Filed 2023-06-12 09:36 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$254,188
+21,800 vol $11.66 each |
76,200 | |
| Filed 2023-06-12 09:36 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,304
+54,400 vol $11.66 each |
54,400 | |
| Filed 2023-06-12 09:34 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
| Filed 2023-06-12 09:32 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
118,200 | |
| Filed 2023-06-12 09:30 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
| Filed 2023-06-09 16:09 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 16:07 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 16:05 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 16:02 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 15:58 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 15:53 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 15:50 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
||
| Filed 2023-06-09 15:46 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$254,188
+21,800 vol $11.66 each |
||
| Filed 2023-06-09 15:29 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$634,304
+54,400 vol $11.66 each |
||
| Filed 2023-06-09 16:09 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
168,133 | |
| Filed 2023-06-09 16:07 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
187,928 | |
| Filed 2023-06-09 16:05 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
168,133 | |
| Filed 2023-06-09 16:02 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
| Filed 2023-06-09 15:58 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
136,107 | |
| Filed 2023-06-09 15:53 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
118,200 | |
| Filed 2023-06-09 15:50 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$317,152
+27,200 vol $11.66 each |
97,200 | |
| Filed 2023-06-09 15:46 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$254,188
+21,800 vol $11.66 each |
76,200 | |
| Filed 2023-06-09 15:29 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$634,304
+54,400 vol $11.66 each |
54,400 | |
| Filed 2023-06-09 15:27 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Molineaux, Susan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-09 08:16 Tx date 2023-06-08 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-34,475.9123
-2,869 vol $12.02 each |
35,568 | |
| Filed 2023-06-08 14:18 Tx date 2023-06-07 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-77,045.8836
-6,404 vol $12.03 each |
38,437 | |
| Filed 2023-06-06 17:16 Tx date 2023-06-06 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-14,448.96
-1,200 vol $12.04 each |
44,841 | |
| Filed 2023-05-29 13:16 Tx date 2023-05-18 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,359,200
+240,000 vol $9.83 each |
240,000 | |
| Filed 2023-05-29 12:57 Tx date 2023-05-09 |
$RPTX
Repare Therapeutics Inc. |
Bélanger, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-13 17:13 Tx date 2023-02-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+50,000 vol |
66,850 | |
| Filed 2023-02-02 18:54 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+17,250 vol |
17,250 | |
| Filed 2023-02-02 18:53 Tx date 2022-01-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:53 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$936,468
+75,400 vol $12.42 each |
325,400 | |
| Filed 2023-02-02 18:46 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+24,530 vol |
24,530 | |
| Filed 2023-02-02 18:45 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:45 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,379,241
+111,050 vol $12.42 each |
649,090 | |
| Filed 2023-02-02 18:35 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+26,450 vol |
26,450 | |
| Filed 2023-02-02 18:34 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:34 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,481,085
+119,250 vol $12.42 each |
556,156 | |
| Filed 2023-02-02 18:31 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+16,850 vol |
16,850 | |
| Filed 2023-02-02 18:31 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:30 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$915,354
+73,700 vol $12.42 each |
542,139 | |
| Filed 2023-02-02 18:28 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+11,230 vol |
11,230 | |
| Filed 2023-02-02 18:27 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:27 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$607,834
+48,940 vol $12.42 each |
492,396 | |
| Filed 2023-02-02 18:22 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+24,550 vol |
24,550 | |
| Filed 2023-02-02 18:17 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:17 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,205,982
+97,100 vol $12.42 each |
551,593 | |
| Filed 2023-02-02 18:11 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+78,550 vol |
78,550 | |
| Filed 2023-02-02 18:10 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:09 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
2,166,376 | |
| Filed 2023-02-02 17:55 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
||
| Filed 2023-02-02 17:53 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
||
| Filed 2023-01-03 10:53 Tx date 2022-12-29 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+3,014 vol |
25,131 | |
| Filed 2023-01-03 10:52 Tx date 2022-12-29 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,240 vol |
22,117 | |
| Filed 2022-12-22 17:01 Tx date 2022-01-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-21 22:09 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-12-21 17:00 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
12,312 | |
| Filed 2022-12-21 16:56 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
19,804 | |
| Filed 2022-12-21 16:53 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
46,041 | |
| Filed 2022-12-21 16:49 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
101,006 | |
| Filed 2022-12-21 16:39 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2022-12-21 09:24 Tx date 2022-12-20 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$714,508
+48,507 vol $14.73 each |
149,513 | |
| Filed 2022-12-21 09:21 Tx date 2022-12-20 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-714,508.11
-48,507 vol $14.73 each |
436,906 | |
| Filed 2022-03-15 18:51 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
||
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:22 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2021-12-10 17:13 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
||
| Filed 2021-12-07 09:43 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
||
| Filed 2022-07-28 09:33 Tx date 2021-08-05 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+19 vol |
11,776 | |
| Filed 2022-07-28 09:31 Tx date 2021-06-01 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+9 vol |
11,757 | |
| Filed 2022-07-28 09:30 Tx date 2021-05-05 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,842 vol |
11,748 | |
| Filed 2022-07-28 09:28 Tx date 2021-02-16 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+830 vol |
8,906 | |
| Filed 2022-07-28 09:27 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+5,277 vol |
8,076 | |
| Filed 2022-07-28 09:25 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,799 vol |
2,799 | |
| Filed 2022-07-06 11:21 Tx date 2022-06-30 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$573,600
+40,000 vol $14.34 each |
250,000 | |
| Filed 2022-06-24 13:13 Tx date 2022-06-23 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,358,000
+100,000 vol $13.58 each |
468,439 | |
| Filed 2022-06-10 09:52 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+6,448 vol |
9,101 | |
| Filed 2022-06-10 09:51 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,653 vol |
2,653 | |
| Filed 2022-06-10 09:46 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-08 12:09 Tx date 2022-06-03 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,062,925
-250,000 vol $12.25 each |
2,344,451 | |
| Filed 2022-06-08 12:07 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-260,539.80
-18,478 vol $14.10 each |
25,587 | |
| Filed 2022-06-08 12:05 Tx date 2022-06-03 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-161,710.1883
-13,199 vol $12.25 each |
44,065 | |
| Filed 2022-06-08 12:02 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-288,401.40
-20,454 vol $14.10 each |
28,322 | |
| Filed 2022-06-08 12:01 Tx date 2022-06-03 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-179,009.5887
-14,611 vol $12.25 each |
48,776 | |
| Filed 2022-06-08 11:59 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-659,217.30
-46,753 vol $14.10 each |
64,731 | |
| Filed 2022-06-08 11:58 Tx date 2022-06-03 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-409,145.5215
-33,395 vol $12.25 each |
111,484 | |
| Filed 2022-06-08 11:55 Tx date 2022-06-06 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-8,661,841.50
-614,315 vol $14.10 each |
850,560 | |
| Filed 2022-06-08 11:54 Tx date 2022-06-03 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,375,984.7015
-438,795 vol $12.25 each |
1,464,875 | |
| Filed 2022-05-16 15:08 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
91,000 | |
| Filed 2022-05-16 15:04 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
108,907 | |
| Filed 2022-05-16 14:52 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
140,933 | |
| Filed 2022-05-16 14:45 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
160,728 | |
| Filed 2022-05-16 14:42 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
140,933 | |
| Filed 2022-05-16 14:39 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
70,000 | |
| Filed 2022-05-16 14:31 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
70,000 | |
| Filed 2022-05-16 14:27 Tx date 2022-05-13 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$467,950
+49,000 vol $9.55 each |
70,000 | |
| Filed 2022-03-15 18:51 Tx date 2022-03-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,022.90
-533 vol $11.30 each |
46,041 | |
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-02-28 20:29 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,157 | |
| Filed 2022-02-28 20:22 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
19,804 | |
| Filed 2022-01-24 12:08 Tx date 2022-01-21 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
1,822,176 | |
| Filed 2022-01-20 19:28 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
||
| Filed 2022-01-21 11:39 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,813,400
+180,000 vol $15.63 each |
180,000 | |
| Filed 2022-01-21 11:37 Tx date 2022-01-01 |
$RPTX
Repare Therapeutics Inc. |
Herman, Philip
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-20 19:37 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Akiyoshi, Laurence
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,031,580
+66,000 vol $15.63 each |
246,722 | |
| Filed 2022-01-20 19:28 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
1,822,176 | |
| Filed 2022-01-20 19:25 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,126,000
+200,000 vol $15.63 each |
368,439 | |
| Filed 2022-01-20 19:16 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,250,400
+80,000 vol $15.63 each |
443,456 | |
| Filed 2022-01-20 19:13 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,797,450
+115,000 vol $15.63 each |
454,493 | |
| Filed 2022-01-20 19:10 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,797,450
+115,000 vol $15.63 each |
485,413 | |
| Filed 2022-01-20 19:06 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,563,000
+100,000 vol $15.63 each |
538,040 | |
| Filed 2021-12-10 17:17 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$99,924
+48,460 vol $2.06 each |
100,955 | |
| Filed 2021-12-10 17:16 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-123.675
-51 vol $2.42 each |
370,413 | |
| Filed 2021-12-10 17:15 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-99,924.52
-48,460 vol $2.06 each |
370,464 | |
| Filed 2021-12-10 17:14 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-99,924.52
-48,460 vol $2.06 each |
||
| Filed 2021-12-10 17:13 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
101,006 | |
| Filed 2021-12-10 17:13 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$99,924
+48,460 vol $2.06 each |
||
| Filed 2021-12-10 17:11 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$123.67
+51 vol $2.42 each |
||
| Filed 2021-12-10 17:11 Tx date 2021-12-10 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$99,924
+48,460 vol $2.06 each |
||
| Filed 2021-12-07 09:43 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,323
+2,962 vol $13.28 each |
12,312 | |
| Filed 2021-12-07 09:43 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,184
+2,138 vol $2.42 each |
9,350 | |
| Filed 2021-12-07 09:42 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,546
+1,720 vol $2.06 each |
7,212 | |
| Filed 2021-12-07 09:42 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,058
+3,090 vol $1.64 each |
5,492 | |
| Filed 2021-12-07 09:41 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,807
+1,715 vol $1.64 each |
2,402 | |
| Filed 2021-12-07 09:41 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,962 vol |
168,439 | |
| Filed 2021-12-07 09:40 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,138 vol |
171,401 | |
| Filed 2021-12-07 09:39 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,720 vol |
173,539 | |
| Filed 2021-12-07 09:38 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,090 vol |
175,259 | |
| Filed 2021-12-07 09:38 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,715 vol |
178,349 | |
| Filed 2021-12-07 09:32 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,397
+10,473 vol $2.42 each |
46,574 | |
| Filed 2021-12-07 09:32 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,394
+19,590 vol $2.06 each |
36,101 | |
| Filed 2021-12-07 09:31 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,408
+11,856 vol $1.64 each |
16,511 | |
| Filed 2021-12-07 09:31 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,747
+4,122 vol $1.64 each |
4,655 | |
| Filed 2021-12-07 09:30 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-10,473 vol |
339,493 | |
| Filed 2021-12-07 09:30 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-19,590 vol |
349,966 | |
| Filed 2021-12-07 09:29 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-11,856 vol |
369,556 | |
| Filed 2021-12-07 09:28 Tx date 2021-12-02 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-4,122 vol |
381,412 | |
| Filed 2021-11-17 11:49 Tx date 2021-11-16 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,622
+7,500 vol $28.08 each |
7,500 | |
| Filed 2021-11-17 11:03 Tx date 2021-11-15 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-546,560
-20,000 vol $27.33 each |
533 | |
| Filed 2021-10-07 09:55 Tx date 2021-10-05 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-64,417
-2,500 vol $25.77 each |
19,075 | |
| Filed 2021-10-07 09:55 Tx date 2021-08-10 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-59,735.1865
-1,705 vol $35.04 each |
21,242 | |
| Filed 2021-10-07 09:54 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-27,830.565
-795 vol $35.01 each |
22,947 | |
| Filed 2021-10-07 09:54 Tx date 2021-07-06 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-76,513.50
-2,500 vol $30.61 each |
23,742 | |
| Filed 2021-10-06 10:46 Tx date 2021-10-05 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,417
-2,500 vol $25.77 each |
||
| Filed 2021-10-06 10:44 Tx date 2021-08-10 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,735.1865
-1,705 vol $35.04 each |
||
| Filed 2021-10-06 10:43 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,830.565
-795 vol $35.01 each |
||
| Filed 2021-10-06 10:42 Tx date 2021-07-06 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,513.50
-2,500 vol $30.61 each |
||
| Filed 2021-10-06 11:12 Tx date 2021-08-13 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,180
+428 vol $28.46 each |
5,428 | |
| Filed 2021-10-06 11:09 Tx date 2021-08-13 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,327
+398 vol $28.46 each |
5,398 | |
| Filed 2021-10-06 11:05 Tx date 2021-08-13 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,477
+333 vol $28.46 each |
21,575 | |
| Filed 2021-10-06 10:46 Tx date 2021-10-05 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,417
-2,500 vol $25.77 each |
18,742 | |
| Filed 2021-10-06 10:44 Tx date 2021-08-10 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,735.1865
-1,705 vol $35.04 each |
21,242 | |
| Filed 2021-10-06 10:43 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,830.565
-795 vol $35.01 each |
22,947 | |
| Filed 2021-10-06 10:42 Tx date 2021-07-06 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,513.50
-2,500 vol $30.61 each |
23,742 | |
| Filed 2021-09-21 19:51 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,640.42
-214 vol $31.03 each |
687 | |
| Filed 2021-09-21 19:50 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,459.20
-80 vol $30.74 each |
901 | |
| Filed 2021-09-21 19:50 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
981 | |
| Filed 2021-09-21 19:49 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,280
+214 vol $20.00 each |
901 | |
| Filed 2021-09-21 19:42 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
180,064 | |
| Filed 2021-09-21 19:40 Tx date 2021-09-21 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,280
-214 vol $20.00 each |
180,144 | |
| Filed 2021-09-10 14:28 Tx date 2021-09-07 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,423,380
+42,000 vol $33.89 each |
42,000 | |
| Filed 2021-09-10 12:47 Tx date 2021-09-07 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-10 12:47 Tx date 2021-09-07 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,423,380
+42,000 vol $33.89 each |
42,000 | |
| Filed 2021-09-10 12:47 Tx date 2021-09-07 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,423,380
+42,000 vol $33.89 each |
||
| Filed 2021-09-10 12:45 Tx date 2021-09-07 |
$RPTX
Repare Therapeutics Inc. |
Civik, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-10 08:47 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-430 vol $34.00 each |
687 | |
| Filed 2021-09-10 08:45 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,504.49
-429 vol $33.81 each |
1,117 | |
| Filed 2021-09-10 08:45 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,708
+430 vol $13.28 each |
1,546 | |
| Filed 2021-09-10 08:44 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,695
+429 vol $13.28 each |
1,116 | |
| Filed 2021-09-10 08:43 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,708.68
-430 vol $13.28 each |
180,358 | |
| Filed 2021-09-10 08:42 Tx date 2021-09-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,695.404
-429 vol $13.28 each |
180,788 | |
| Filed 2021-08-19 18:40 Tx date 2021-08-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,586
-429 vol $34.00 each |
687 | |
| Filed 2021-08-19 18:38 Tx date 2021-08-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,580
+429 vol $20.00 each |
1,116 | |
| Filed 2021-08-19 18:37 Tx date 2021-08-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,580
-429 vol $20.00 each |
181,217 | |
| Filed 2021-08-19 16:20 Tx date 2021-08-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-509,872.50
-15,000 vol $33.99 each |
20,533 | |
| Filed 2021-08-19 13:31 Tx date 2021-08-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,423.49
-159 vol $34.11 each |
687 | |
| Filed 2021-08-19 13:31 Tx date 2021-08-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$385.57
+159 vol $2.42 each |
846 | |
| Filed 2021-08-19 13:30 Tx date 2021-08-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-385.575
-159 vol $2.42 each |
181,646 | |
| Filed 2021-08-09 17:45 Tx date 2021-08-05 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-5,358,982.04
-152,071 vol $35.24 each |
231,211 | |
| Filed 2021-08-04 10:57 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,856.50
-430 vol $34.55 each |
687 | |
| Filed 2021-08-04 10:57 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,821.95
-429 vol $34.55 each |
1,117 | |
| Filed 2021-08-04 10:56 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,708
+430 vol $13.28 each |
1,546 | |
| Filed 2021-08-04 10:55 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,695
+429 vol $13.28 each |
1,116 | |
| Filed 2021-08-04 10:54 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,708.68
-430 vol $13.28 each |
181,805 | |
| Filed 2021-08-04 10:54 Tx date 2021-08-02 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,695.404
-429 vol $13.28 each |
182,235 | |
| Filed 2021-07-22 20:34 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,310
-215 vol $34.00 each |
687 | |
| Filed 2021-07-22 20:33 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,686
-79 vol $34.00 each |
902 | |
| Filed 2021-07-22 20:32 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,300
+215 vol $20.00 each |
981 | |
| Filed 2021-07-22 20:31 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$191.57
+79 vol $2.42 each |
766 | |
| Filed 2021-07-22 20:30 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,300
-215 vol $20.00 each |
182,664 | |
| Filed 2021-07-22 20:29 Tx date 2021-07-20 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-191.575
-79 vol $2.42 each |
182,879 | |
| Filed 2021-07-22 19:50 Tx date 2021-07-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,642.56
-214 vol $31.04 each |
687 | |
| Filed 2021-07-22 19:50 Tx date 2021-07-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,280
+214 vol $20.00 each |
901 | |
| Filed 2021-07-22 19:49 Tx date 2021-07-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,280
-214 vol $20.00 each |
182,958 | |
| Filed 2021-07-20 17:10 Tx date 2021-07-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,345.60
-80 vol $29.32 each |
687 | |
| Filed 2021-07-20 17:10 Tx date 2021-07-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-07-20 17:09 Tx date 2021-07-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
183,172 | |
| Filed 2021-07-08 20:30 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,620
-430 vol $34.00 each |
687 | |
| Filed 2021-07-08 20:29 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,448.72
-429 vol $33.68 each |
1,117 | |
| Filed 2021-07-08 20:29 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,708
+430 vol $13.28 each |
1,546 | |
| Filed 2021-07-08 20:28 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,695
+429 vol $13.28 each |
1,116 | |
| Filed 2021-07-08 20:28 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,708.68
-430 vol $13.28 each |
183,252 | |
| Filed 2021-07-08 20:27 Tx date 2021-07-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,695.404
-429 vol $13.28 each |
183,682 | |
| Filed 2021-06-29 14:42 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,970
-1,542 vol $35.00 each |
94,466 | |
| Filed 2021-06-29 11:56 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,618
-2,577 vol $34.00 each |
687 | |
| Filed 2021-06-29 11:56 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-84,678.6738
-2,577 vol $32.86 each |
3,264 | |
| Filed 2021-06-29 11:55 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$51,540
+2,577 vol $20.00 each |
5,841 | |
| Filed 2021-06-29 11:54 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$51,540
+2,577 vol $20.00 each |
3,264 | |
| Filed 2021-06-29 11:54 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-51,540
-2,577 vol $20.00 each |
184,111 | |
| Filed 2021-06-29 11:53 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-51,540
-2,577 vol $20.00 each |
186,688 | |
| Filed 2021-06-21 20:17 Tx date 2021-06-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,686
-79 vol $34.00 each |
687 | |
| Filed 2021-06-21 20:16 Tx date 2021-06-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$191.57
+79 vol $2.42 each |
766 | |
| Filed 2021-06-21 20:16 Tx date 2021-06-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-191.575
-79 vol $2.42 each |
189,265 | |
| Filed 2021-06-17 20:07 Tx date 2021-06-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,523.20
-80 vol $31.54 each |
687 | |
| Filed 2021-06-17 20:06 Tx date 2021-06-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-06-17 20:06 Tx date 2021-06-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
189,344 | |
| Filed 2021-06-11 10:38 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,354
-1,481 vol $34.00 each |
687 | |
| Filed 2021-06-11 10:38 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-125,223.7875
-3,675 vol $34.07 each |
2,168 | |
| Filed 2021-06-11 10:37 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,661
+1,481 vol $13.28 each |
5,843 | |
| Filed 2021-06-11 10:36 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$48,789
+3,675 vol $13.28 each |
4,362 | |
| Filed 2021-06-11 10:35 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,661.756
-1,481 vol $13.28 each |
189,424 | |
| Filed 2021-06-11 10:33 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-48,789.30
-3,675 vol $13.28 each |
190,905 | |
| Filed 2021-06-11 09:56 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,088.9734
-1,482 vol $32.45 each |
687 | |
| Filed 2021-06-11 09:55 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-119,175.105
-3,675 vol $32.43 each |
2,169 | |
| Filed 2021-06-11 09:54 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,675
+1,482 vol $13.28 each |
5,844 | |
| Filed 2021-06-11 09:53 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$48,789
+3,675 vol $13.28 each |
4,362 | |
| Filed 2021-06-11 09:51 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,675.032
-1,482 vol $13.28 each |
194,580 | |
| Filed 2021-06-11 09:50 Tx date 2021-06-07 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-48,789.30
-3,675 vol $13.28 each |
196,062 | |
| Filed 2021-06-09 17:36 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,160
-1,576 vol $35.00 each |
96,008 | |
| Filed 2021-06-04 17:14 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-908,054.0184
-29,352 vol $30.94 each |
97,584 | |
| Filed 2021-06-04 14:08 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-156,254.50
-5,000 vol $31.25 each |
5,000 | |
| Filed 2021-06-04 14:06 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,185
+5,000 vol $1.64 each |
10,000 | |
| Filed 2021-06-04 14:06 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,185
-5,000 vol $1.64 each |
1,522,176 | |
| Filed 2021-06-04 14:01 Tx date 2021-06-03 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-211,034.112
-6,648 vol $31.74 each |
126,936 | |
| Filed 2021-06-03 12:42 Tx date 2021-06-01 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-75,000 vol |
383,282 | |
| Filed 2021-05-21 09:38 Tx date 2021-05-20 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-132,065.362
-3,770 vol $35.03 each |
133,584 | |
| Filed 2021-05-20 15:17 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,720
-80 vol $34.00 each |
687 | |
| Filed 2021-05-20 15:16 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,720
-80 vol $34.00 each |
767 | |
| Filed 2021-05-20 15:15 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
847 | |
| Filed 2021-05-20 15:15 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-05-20 15:14 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
199,737 | |
| Filed 2021-05-20 15:13 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
199,817 | |
| Filed 2021-05-20 15:02 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
687 | |
| Filed 2021-05-20 15:01 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-05-20 15:00 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
199,897 | |
| Filed 2021-05-20 14:53 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
||
| Filed 2021-05-20 14:53 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
||
| Filed 2021-05-20 14:53 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 14:48 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
||
| Filed 2021-05-20 14:48 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
||
| Filed 2021-05-20 13:57 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
687 | |
| Filed 2021-05-20 13:57 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
||
| Filed 2021-05-20 13:50 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
||
| Filed 2021-05-20 13:50 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
199,897 | |
| Filed 2021-05-20 13:49 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 13:49 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
607 | |
| Filed 2021-05-20 13:48 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-194.00
-80 vol $2.42 each |
||
| Filed 2021-05-20 13:48 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-194.00
-80 vol $2.42 each |
||
| Filed 2021-05-20 13:43 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
199,737 | |
| Filed 2021-05-20 13:43 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
||
| Filed 2021-05-20 13:43 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
199,817 | |
| Filed 2021-05-20 13:43 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,720
-80 vol $34.00 each |
||
| Filed 2021-05-20 13:23 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 13:23 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 13:22 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 13:22 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,580
-80 vol $32.25 each |
||
| Filed 2021-05-20 11:42 Tx date 2021-05-19 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,223.06
-3,800 vol $35.06 each |
137,354 | |
| Filed 2021-05-20 11:32 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,000
-1,800 vol $35.00 each |
141,154 | |
| Filed 2021-05-18 13:13 Tx date 2021-05-17 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-490,710
-15,000 vol $32.71 each |
35,533 | |
| Filed 2021-05-17 16:14 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
91,933 | |
| Filed 2021-05-17 16:01 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-17 16:00 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-17 15:58 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-17 15:56 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
91,933 | |
| Filed 2021-05-17 15:54 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
111,728 | |
| Filed 2021-05-17 15:44 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
59,907 | |
| Filed 2021-05-14 13:26 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 13:18 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 13:15 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 13:00 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 12:46 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 12:44 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 12:38 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
||
| Filed 2021-05-14 13:26 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-14 13:26 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-14 13:18 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
91,933 | |
| Filed 2021-05-14 13:15 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
111,728 | |
| Filed 2021-05-14 13:00 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
91,933 | |
| Filed 2021-05-14 12:46 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
59,907 | |
| Filed 2021-05-14 12:44 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-14 12:43 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Davis, Jerel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-14 12:38 Tx date 2021-05-13 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,240
+21,000 vol $32.44 each |
21,000 | |
| Filed 2021-05-14 12:35 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Foley, Todd
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-10 11:49 Tx date 2021-05-05 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-211,277 vol |
1,903,670 | |
| Filed 2021-05-10 11:47 Tx date 2021-05-05 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-6,355 vol |
57,264 | |
| Filed 2021-05-10 11:45 Tx date 2021-05-05 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-16,079 vol |
144,879 | |
| Filed 2021-05-10 11:43 Tx date 2021-05-05 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-7,035 vol |
63,387 | |
| Filed 2021-04-22 13:33 Tx date 2021-04-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,703.20
-80 vol $33.79 each |
687 | |
| Filed 2021-04-22 13:32 Tx date 2021-04-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-04-22 13:32 Tx date 2021-04-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
199,977 | |
| Filed 2021-04-19 15:00 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,720
-80 vol $34.00 each |
687 | |
| Filed 2021-04-19 14:59 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-04-19 14:59 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
200,057 | |
| Filed 2021-04-19 14:53 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,406
-159 vol $34.00 each |
687 | |
| Filed 2021-04-19 14:53 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$385.57
+159 vol $2.42 each |
846 | |
| Filed 2021-04-19 14:52 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-385.575
-159 vol $2.42 each |
200,137 | |
| Filed 2021-04-19 14:45 Tx date 2021-03-09 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,225
-2,500 vol $26.49 each |
31,242 | |
| Filed 2021-03-10 16:56 Tx date 2021-03-09 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,225
-2,500 vol $26.49 each |
||
| Filed 2021-03-10 16:22 Tx date 2021-03-09 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,500
-2,500 vol $25.00 each |
||
| Filed 2021-04-16 13:20 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192,950.316
-5,512 vol $35.01 each |
142,954 | |
| Filed 2021-04-16 11:35 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-2,500 vol $35.00 each |
26,242 | |
| Filed 2021-04-16 11:31 Tx date 2021-04-01 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,236
-2,500 vol $30.09 each |
28,742 | |
| Filed 2021-04-16 11:18 Tx date 2021-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,320
-80 vol $29.00 each |
687 | |
| Filed 2021-04-16 11:16 Tx date 2021-03-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,611
-159 vol $29.00 each |
687 | |
| Filed 2021-04-15 15:33 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-2,500 vol $35.00 each |
||
| Filed 2021-04-07 10:06 Tx date 2021-04-01 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,236
-2,500 vol $30.09 each |
||
| Filed 2021-03-19 14:01 Tx date 2021-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,320
-80 vol $29.00 each |
||
| Filed 2021-03-17 13:30 Tx date 2021-03-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,611
-159 vol $29.00 each |
||
| Filed 2021-04-15 15:33 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-2,500 vol $35.00 each |
26,242 | |
| Filed 2021-04-07 10:06 Tx date 2021-04-01 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,236
-2,500 vol $30.09 each |
28,742 | |
| Filed 2021-04-02 13:38 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
5,000 | |
| Filed 2021-04-02 13:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
52,495 | ||
| Filed 2020-07-02 20:12 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 20:10 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
||
| Filed 2021-03-19 14:01 Tx date 2021-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,320
-80 vol $29.00 each |
687 | |
| Filed 2021-03-19 14:00 Tx date 2021-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$194.00
+80 vol $2.42 each |
767 | |
| Filed 2021-03-19 14:00 Tx date 2021-03-19 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-194.00
-80 vol $2.42 each |
200,296 | |
| Filed 2021-03-17 13:30 Tx date 2021-03-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,611
-159 vol $29.00 each |
687 | |
| Filed 2021-03-17 13:29 Tx date 2021-03-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$385.57
+159 vol $2.42 each |
846 | |
| Filed 2021-03-17 13:28 Tx date 2021-03-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-385.575
-159 vol $2.42 each |
200,376 | |
| Filed 2021-03-10 16:56 Tx date 2021-03-09 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,225
-2,500 vol $26.49 each |
31,242 | |
| Filed 2021-03-10 16:22 Tx date 2021-03-09 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,500
-2,500 vol $25.00 each |
||
| Filed 2021-02-17 14:50 Tx date 2021-02-16 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-50,000 vol |
458,282 | |
| Filed 2021-02-17 14:48 Tx date 2021-02-16 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
2,594,451 | |
| Filed 2021-02-12 10:28 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,620,609
+71,000 vol $36.91 each |
438,040 | |
| Filed 2021-02-12 10:25 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,613,750
+125,000 vol $36.91 each |
418,924 | |
| Filed 2021-02-12 10:22 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,613,750
+125,000 vol $36.91 each |
1,527,176 | |
| Filed 2021-02-11 17:46 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,613,750
+125,000 vol $36.91 each |
385,534 | |
| Filed 2021-02-11 17:43 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,030,049
+55,000 vol $36.91 each |
200,535 | |
| Filed 2021-02-11 17:41 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,546,789
+69,000 vol $36.91 each |
363,456 | |
| Filed 2021-02-11 17:29 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
Akiyoshi, Laurence
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,214,600
+60,000 vol $36.91 each |
180,722 | |
| Filed 2021-02-02 13:45 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-20,037 vol |
160,958 | |
| Filed 2021-02-02 13:43 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-8,766 vol |
70,422 | |
| Filed 2021-02-02 13:42 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-7,919 vol |
63,619 | |
| Filed 2021-02-02 13:40 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-263,278 vol |
2,114,947 | |
| Filed 2021-02-02 13:38 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-50,000 vol |
508,282 | |
| Filed 2021-02-02 13:36 Tx date 2021-01-29 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-250,000 vol |
2,894,451 | |
| Filed 2021-01-15 14:57 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-4,620 vol |
71,538 | |
| Filed 2021-01-15 14:55 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-50,000 vol |
558,282 | |
| Filed 2021-01-15 14:52 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-11,688 vol |
180,995 | |
| Filed 2021-01-15 14:50 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-5,113 vol |
79,188 | |
| Filed 2021-01-15 14:47 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-275,000 vol |
3,144,451 | |
| Filed 2021-01-15 14:42 Tx date 2021-01-14 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-153,579 vol |
2,378,225 | |
| Filed 2021-01-05 18:51 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
148,466 | |
| Filed 2021-01-05 18:50 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 18:38 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 18:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
5,000 | |
| Filed 2021-01-05 18:34 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
||
| Filed 2021-01-05 18:33 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
||
| Filed 2021-01-05 17:51 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+50,000 vol |
50,533 | |
| Filed 2021-01-05 17:50 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-50,000 vol |
533 | |
| Filed 2021-01-05 17:48 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+20,000 vol |
33,742 | |
| Filed 2021-01-05 17:48 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-20,000 vol |
13,742 | |
| Filed 2021-01-05 17:46 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
+51,931 vol |
145,535 | |
| Filed 2021-01-05 17:45 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
-51,931 vol |
93,604 | |
| Filed 2021-01-05 17:38 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
||
| Filed 2021-01-05 17:38 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
148,467 | |
| Filed 2021-01-05 17:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 17:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1 | ||
| Filed 2021-01-05 17:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
||
| Filed 2021-01-05 17:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
5,000 | |
| Filed 2020-12-30 16:02 Tx date 2020-12-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$354.66
+172 vol $2.06 each |
687 | |
| Filed 2020-12-30 16:01 Tx date 2020-12-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$843.05
+515 vol $1.64 each |
515 | |
| Filed 2020-12-30 15:59 Tx date 2020-12-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-354.664
-172 vol $2.06 each |
145,535 | |
| Filed 2020-12-30 15:58 Tx date 2020-12-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-843.055
-515 vol $1.64 each |
145,707 | |
| Filed 2020-12-30 15:22 Tx date 2020-12-29 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-284,213.358
-8,502 vol $33.43 each |
50,533 | |
| Filed 2020-12-30 15:21 Tx date 2020-12-29 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-207,034.8056
-6,244 vol $33.16 each |
59,035 | |
| Filed 2020-12-30 15:18 Tx date 2020-12-29 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-171,900.63
-4,950 vol $34.73 each |
65,279 | |
| Filed 2020-12-29 15:23 Tx date 2020-12-29 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,820
-1,500 vol $35.88 each |
33,742 | |
| Filed 2020-12-29 11:50 Tx date 2020-12-28 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-1,612.80
-48 vol $33.60 each |
70,229 | |
| Filed 2020-12-29 11:49 Tx date 2020-12-28 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$98.98
+48 vol $2.06 each |
70,277 | |
| Filed 2020-12-29 11:48 Tx date 2020-12-28 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-98.976
-48 vol $2.06 each |
260,534 | |
| Filed 2020-12-29 11:46 Tx date 2020-12-28 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-513,814.50
-15,000 vol $34.25 each |
70,229 | |
| Filed 2020-12-28 11:50 Tx date 2020-12-24 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-14,315.9184
-432 vol $33.14 each |
85,229 | |
| Filed 2020-12-28 11:49 Tx date 2020-12-24 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$890.78
+432 vol $2.06 each |
85,661 | |
| Filed 2020-12-28 11:49 Tx date 2020-12-24 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-890.784
-432 vol $2.06 each |
260,582 | |
| Filed 2020-12-24 12:01 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-162,023.16
-4,771 vol $33.96 each |
85,229 | |
| Filed 2020-12-24 12:00 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-66,393.60
-1,976 vol $33.60 each |
90,000 | |
| Filed 2020-12-24 11:59 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-316,709.44
-9,488 vol $33.38 each |
91,976 | |
| Filed 2020-12-24 11:59 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,837
+4,771 vol $2.06 each |
101,464 | |
| Filed 2020-12-24 11:58 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,234
+1,976 vol $1.64 each |
96,693 | |
| Filed 2020-12-24 11:58 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,008
+9,488 vol $2.42 each |
94,717 | |
| Filed 2020-12-24 11:57 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,837.802
-4,771 vol $2.06 each |
261,014 | |
| Filed 2020-12-24 11:57 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,234.712
-1,976 vol $1.64 each |
265,785 | |
| Filed 2020-12-24 11:56 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-23,008.40
-9,488 vol $2.42 each |
267,761 | |
| Filed 2020-12-23 18:10 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-44,608
-1,312 vol $34.00 each |
85,229 | |
| Filed 2020-12-23 18:08 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-1,334,772
-40,000 vol $33.37 each |
86,541 | |
| Filed 2020-12-23 17:55 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-524,412.3458
-15,706 vol $33.39 each |
||
| Filed 2020-12-23 17:55 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-524,412.3458
-15,706 vol $33.39 each |
100,044 | |
| Filed 2020-12-23 17:53 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-360,303.9363
-10,791 vol $33.39 each |
115,750 | |
| Filed 2020-12-23 17:53 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-360,303.9363
-10,791 vol $33.39 each |
||
| Filed 2020-12-23 17:53 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,251
+10,791 vol $2.06 each |
126,541 | |
| Filed 2020-12-23 17:52 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,710
+15,706 vol $1.64 each |
115,750 | |
| Filed 2020-12-23 17:52 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,548
+14,815 vol $2.06 each |
100,044 | |
| Filed 2020-12-23 17:51 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,548.53
-14,815 vol $2.06 each |
277,249 | |
| Filed 2020-12-23 17:50 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-22,251.042
-10,791 vol $2.06 each |
292,064 | |
| Filed 2020-12-23 17:49 Tx date 2020-12-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,710.722
-15,706 vol $1.64 each |
302,855 | |
| Filed 2020-12-23 16:53 Tx date 2020-12-23 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-51,375
-1,500 vol $34.25 each |
35,242 | |
| Filed 2020-12-22 16:29 Tx date 2020-12-21 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-1,323,196
-40,000 vol $33.08 each |
85,229 | |
| Filed 2020-12-22 16:28 Tx date 2020-12-21 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$97,000
+40,000 vol $2.42 each |
125,229 | |
| Filed 2020-12-22 16:27 Tx date 2020-12-21 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-97,000
-40,000 vol $2.42 each |
318,561 | |
| Filed 2020-12-18 20:08 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-165,953.5808
-4,816 vol $34.46 each |
85,229 | |
| Filed 2020-12-18 20:08 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,930
+4,816 vol $2.06 each |
90,045 | |
| Filed 2020-12-18 20:07 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,930.592
-4,816 vol $2.06 each |
358,561 | |
| Filed 2020-12-18 19:57 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-121,985.5665
-3,505 vol $34.80 each |
85,229 | |
| Filed 2020-12-18 19:56 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,227
+3,505 vol $2.06 each |
88,734 | |
| Filed 2020-12-18 19:55 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,227.31
-3,505 vol $2.06 each |
363,377 | |
| Filed 2020-12-18 18:46 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,686
-1,079 vol $34.00 each |
0 | |
| Filed 2020-12-18 18:45 Tx date 2020-12-18 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,544
-516 vol $34.00 each |
1,079 | |
| Filed 2020-12-18 17:55 Tx date 2020-12-15 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-285,217 vol |
2,531,804 | |
| Filed 2020-12-18 17:52 Tx date 2020-12-15 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-8,579 vol |
76,158 | |
| Filed 2020-12-18 17:50 Tx date 2020-12-15 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-21,707 vol |
192,683 | |
| Filed 2020-12-18 17:45 Tx date 2020-12-15 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-9,497 vol |
84,301 | |
| Filed 2020-12-18 14:08 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-279,108.60
-7,950 vol $35.11 each |
1,595 | |
| Filed 2020-12-18 14:07 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,000,047.6906
-28,921 vol $34.58 each |
9,545 | |
| Filed 2020-12-18 14:06 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,595.178
-890 vol $35.50 each |
38,466 | |
| Filed 2020-12-17 17:00 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-126,500.6925
-3,627 vol $34.88 each |
39,356 | |
| Filed 2020-12-17 16:59 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,795
+3,627 vol $2.42 each |
42,983 | |
| Filed 2020-12-17 16:59 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,795.475
-3,627 vol $2.42 each |
146,222 | |
| Filed 2020-12-17 16:47 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-17,500.40
-500 vol $35.00 each |
39,356 | |
| Filed 2020-12-17 16:46 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,212
+500 vol $2.42 each |
39,856 | |
| Filed 2020-12-17 16:45 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,212.50
-500 vol $2.42 each |
149,849 | |
| Filed 2020-12-17 16:35 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$354.66
+172 vol $2.06 each |
39,356 | |
| Filed 2020-12-17 16:34 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$563.13
+344 vol $1.64 each |
39,184 | |
| Filed 2020-12-17 16:33 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-354.664
-172 vol $2.06 each |
150,349 | |
| Filed 2020-12-17 16:32 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-563.128
-344 vol $1.64 each |
150,521 | |
| Filed 2020-12-17 15:55 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-242,421.6312
-6,876 vol $35.26 each |
85,229 | |
| Filed 2020-12-17 15:46 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,256
+6,876 vol $1.64 each |
92,105 | |
| Filed 2020-12-17 15:45 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,256.012
-6,876 vol $1.64 each |
366,882 | |
| Filed 2020-12-17 12:11 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-73,332.896
-2,080 vol $35.26 each |
85,229 | |
| Filed 2020-12-17 12:09 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,404
+2,080 vol $1.64 each |
87,309 | |
| Filed 2020-12-17 12:06 Tx date 2020-12-16 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,404.96
-2,080 vol $1.64 each |
373,758 | |
| Filed 2020-11-25 11:27 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$354.66
+172 vol $2.06 each |
38,840 | |
| Filed 2020-11-25 11:26 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,814
+1,719 vol $1.64 each |
38,668 | |
| Filed 2020-11-25 11:10 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-354.664
-172 vol $2.06 each |
150,865 | |
| Filed 2020-11-25 11:08 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,814.003
-1,719 vol $1.64 each |
151,037 | |
| Filed 2020-11-25 11:03 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$354.66
+172 vol $2.06 each |
||
| Filed 2020-11-25 11:02 Tx date 2020-11-24 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,814
+1,719 vol $1.64 each |
||
| Filed 2020-11-11 16:13 Tx date 2020-11-11 |
$RPTX
Repare Therapeutics Inc. |
Akiyoshi, Laurence
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,097,600
+110,000 vol $28.16 each |
120,722 | |
| Filed 2020-11-11 16:10 Tx date 2020-11-02 |
$RPTX
Repare Therapeutics Inc. |
Akiyoshi, Laurence
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,722 | ||
| Filed 2020-11-11 16:08 Tx date 2020-11-02 |
$RPTX
Repare Therapeutics Inc. |
Akiyoshi, Laurence
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,750 | ||
| Filed 2020-10-01 11:54 Tx date 2020-09-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-709.328
-344 vol $2.06 each |
152,756 | |
| Filed 2020-10-01 11:53 Tx date 2020-09-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,407.82
-860 vol $1.64 each |
153,100 | |
| Filed 2020-10-01 11:49 Tx date 2020-09-30 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$38,323
+1,204 vol $31.83 each |
36,949 | |
| Filed 2020-08-31 14:45 Tx date 2020-08-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$197,067
+7,908 vol $24.92 each |
35,745 | |
| Filed 2020-08-31 14:41 Tx date 2020-08-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,666.376
-2,748 vol $2.06 each |
153,960 | |
| Filed 2020-08-31 14:39 Tx date 2020-08-28 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,446.92
-5,160 vol $1.64 each |
156,708 | |
| Filed 2020-07-08 14:15 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
21,692 | ||
| Filed 2020-07-02 20:47 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-03 12:59 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+111,361 vol |
2,817,021 | |
| Filed 2020-07-02 21:41 Tx date 2020-03-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+111,361 vol |
||
| Filed 2020-07-02 21:41 Tx date 2020-03-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+111,361 vol |
762,823 | |
| Filed 2020-07-02 21:40 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-111,361 vol |
0 | |
| Filed 2020-07-02 21:39 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,054,198 vol |
2,817,021 | |
| Filed 2020-07-02 21:38 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
36 - Conversion or exchange
|
-2,054,198 vol |
0 | |
| Filed 2020-07-02 21:37 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
651,462 | ||
| Filed 2020-07-02 21:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
111,361 | ||
| Filed 2020-07-02 21:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
2,054,198 | ||
| Filed 2020-07-02 21:34 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$3,000,000
+150,000 vol $20.00 each |
608,282 | |
| Filed 2020-07-02 21:33 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+458,282 vol |
458,282 | |
| Filed 2020-07-02 21:32 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 21:32 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-458,282 vol |
0 | |
| Filed 2020-07-02 21:31 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VANTAGE I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
458,282 | ||
| Filed 2020-07-02 21:27 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+3,350 vol |
84,737 | |
| Filed 2020-07-02 21:26 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-3,350 vol |
0 | |
| Filed 2020-07-02 21:25 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+61,791 vol |
81,387 | |
| Filed 2020-07-02 21:25 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
36 - Conversion or exchange
|
-61,791 vol |
0 | |
| Filed 2020-07-02 21:24 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
19,596 | ||
| Filed 2020-07-02 21:23 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
3,350 | ||
| Filed 2020-07-02 21:23 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT AFFILIATES FUND V, L.P
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
61,791 | ||
| Filed 2020-07-02 21:12 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+8,475 vol |
214,390 | |
| Filed 2020-07-02 21:11 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-8,475 vol |
0 | |
| Filed 2020-07-02 21:09 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+156,335 vol |
205,915 | |
| Filed 2020-07-02 21:08 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
36 - Conversion or exchange
|
-156,335 vol |
0 | |
| Filed 2020-07-02 21:08 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
49,580 | ||
| Filed 2020-07-02 21:07 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
8,475 | ||
| Filed 2020-07-02 21:06 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL V (CANADA) LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
156,335 | ||
| Filed 2020-07-02 20:50 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+3,708 vol |
103,798 | |
| Filed 2020-07-02 20:49 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-3,708 vol |
0 | |
| Filed 2020-07-02 20:48 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+68,398 vol |
100,090 | |
| Filed 2020-07-02 20:48 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
36 - Conversion or exchange
|
-68,398 vol |
0 | |
| Filed 2020-07-02 20:47 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
31,692 | ||
| Filed 2020-07-02 20:47 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
3,708 | ||
| Filed 2020-07-02 20:46 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
68,398 | ||
| Filed 2020-07-02 20:35 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,000,000
+100,000 vol $20.00 each |
3,419,451 | |
| Filed 2020-07-02 20:34 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+875,568 vol |
3,319,451 | |
| Filed 2020-07-02 20:33 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
36 - Conversion or exchange
|
-875,568 vol |
0 | |
| Filed 2020-07-02 20:32 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,443,883 vol |
2,443,883 | |
| Filed 2020-07-02 20:31 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 20:30 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
36 - Conversion or exchange
|
-2,443,883 vol |
0 | |
| Filed 2020-07-02 20:25 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class B convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
875,568 | ||
| Filed 2020-07-02 20:25 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
VERSANT VENTURE CAPITAL VI, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Preferred Shares class A convertible preferred shares
00 - Opening Balance-Initial SEDI Report
|
2,443,883 | ||
| Filed 2020-07-02 20:22 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
27,837 | ||
| Filed 2020-07-02 20:21 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Seth, Kim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
161,868 | ||
| Filed 2020-07-02 20:19 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+3,750 vol $20.00 each |
36,742 | |
| Filed 2020-07-02 20:18 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,992 | ||
| Filed 2020-07-02 20:17 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Black, Cameron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
294,456 | ||
| Filed 2020-07-02 20:16 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
85,229 | ||
| Filed 2020-07-02 20:14 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Zinda, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
375,838 | ||
| Filed 2020-07-02 20:12 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
52,495 | ||
| Filed 2020-07-02 20:11 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Koehler, Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
293,924 | ||
| Filed 2020-07-02 20:10 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
5,000 | |
| Filed 2020-07-02 20:09 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 20:08 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
367,040 | ||
| Filed 2020-07-02 20:05 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$80,000
+4,000 vol $20.00 each |
4,000 | |
| Filed 2020-07-02 20:03 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 20:02 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Rhoads, Ann D.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
38,907 | ||
| Filed 2020-07-02 20:00 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$160,000
+8,000 vol $20.00 each |
8,000 | |
| Filed 2020-07-02 19:59 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 19:59 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Schafer, Carol A.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,933 | ||
| Filed 2020-07-02 19:57 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$96,000
+4,800 vol $20.00 each |
4,800 | |
| Filed 2020-07-02 19:56 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 19:55 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Morrison, Briggs
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,728 | ||
| Filed 2020-07-02 19:52 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
Samarth, Kulkarni
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,933 | ||
| Filed 2020-07-02 19:48 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
153,466 | |
| Filed 2020-07-02 19:47 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
148,466 | ||
| Filed 2020-07-02 19:46 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,402,176 |